VGX-1027
VGX-1027 物理性質
- 融点 :
- 157-158℃
- 貯蔵温度 :
- Sealed in dry,2-8°C
- 溶解性:
- DMSO に可溶 (最大 30 mg/ml)。
- 外見 :
- 個体
- 色:
- 白い
- 安定性::
- -20°C の DMSO 溶液で最大 3 か月間保存できます。
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQJ-3060 |
(3-Phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid |
6501-72-0 |
100mg |
¥77500 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TOC3270 |
GIT 27 |
6501-72-0 |
50mg |
¥179000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQJ-3060 |
(3-Phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid |
6501-72-0 |
250mg |
¥125000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQJ-3060 |
(3-Phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid |
6501-72-0 |
1g |
¥270000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TOC3270 |
GIT 27 |
6501-72-0 |
10mg |
¥43000 |
2024-03-01 |
購入 |
VGX-1027 化学特性,用途語,生産方法
外観
白色~黄赤色~緑色粉末~結晶
使用
2-(3-Phenyl-4,5-dihydroisoxazol-5-yl)acetic Acid reduces the secretion of IL-1β, TNF-α and IL-10 from purified murine macrophages but not of T cells; and reduces the activation of NF-κB and p38 MAP kinase pathways along with up-regulation of ERK pathways. 2-(3-Phenyl-4,5-dihydroisoxazol-5-yl)acetic Acid inhibits proliferation of enterobacterial antigen-reactive CD4+CD25- T cells in vitro .
VGX-1027 上流と下流の製品情報
原材料
準備製品
VGX-1027 生産企業
Global( 88)Suppliers
6501-72-0(VGX-1027)キーワード:
- 6501-72-0
- 4,5-Dihydro-3-phenyl-5-isoxazoleaceticacid
- GIT 27
- VGX-1027
- 2-(3-PHENYL-4,5-DIHYDROISOXAZOL-5-YL)ACETIC ACID
- 3-Phenyl-2-isoxazoline-5-acetic acid
- VGX 1027 3-Phenyl-2-isoxazoline-5-acetic acid
- (S,R)-3-Phenyl-4,5-dihydro-5-isoxasole acetic acid
- 2-Isoxazoline-5-acetic acid, 3-phenyl-
- 5-Isoxazoleacetic acid, 4,5-dihydro-3-phenyl-
- VGX-1027, >=98%
- VGX-127
- VGX-1027, 6501-72-0
- (3-Phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid
- 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid
- GIT27; GIT27; GIT-27; VGX1027; VGX 1027
- VGX-1027(GIT 27)
- CS-1488
- VGX-1027,Tumor Necrosis Factor Receptor,inhibit,Interleukin Related,GIT27,GIT-27,Inhibitor,TNF Receptor,TNFR
- VGX-1027